M. Laplante

Molecular Biology · 2007–2013

A researcher in the Science corpus: 7 papers; trusts 71 researchers and is trusted by 16 researchers here, as inferred from the citation graph.

Subfields

Whom M. Laplante trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. K. Inoki
  2. Dos D. Sarbassov
  3. Y. Sancak
  4. B. Manning
  5. David M. Sabatini
  6. Timothy R. Peterson
  7. C. Thoreen
  8. D. Guertin
  9. S. Kersten
  10. Siraj M. Ali

Who trusts M. Laplante overall

  1. David M. Sabatini
  2. F. Platt
  3. L. Bar-Peled
  4. Y. Sancak
  5. L. Galluzzi
  6. K. Tormos
  7. Christian C. Dibble
  8. T. Balla
  9. Zachary E. Stine
  10. N. Daniel

Papers from M. Laplante's perspective

Ordered by how strongly the researchers M. Laplante trusts endorse each paper. Same corpus, a different order for every researcher.

  1. TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
  2. TOR signaling in growth and metabolism. (Cell)
  3. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
  4. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. (Molecules and Cells)
  5. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
  6. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
  7. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. (Molecules and Cells)
  8. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (Cell)
  9. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. (Molecules and Cells)
  10. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)

Their papers